Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
The clinical trial update documents results from a completed study evaluating the response of metastatic spinal bone marrow to radiation the…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521 [Phase 1]
First-in-human Phase 1 dose-escalation and expansion study of the antibody-drug conjugate BYON3521 in solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors [Phase 1, Phase 2]
Clinical trial update for PRS-344/S095012 (PD-L1x4-1BB bispecific antibody-anticalin fusion) in solid tumors; the Phase 1/Phase 2 study spon…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study of BNT151 in monotherapy and in combination with other anti-cancer agents for solid tumors has been terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 dose-escalation and expansion study of XL495 in locally advanced or metastatic solid tumors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-23Clinical Trial Update: A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluating ES102, an OX40 agonist, in combination with JS001 in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors [NA]
This is a trial update indicating the completion of a clinical trial evaluating a yoga program to improve cancer-related stress in cancer su…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas [Phase 1, Phase 2]
The PROCLAIM-CX-072 Phase 1/2 trial evaluating CX-072 for solid tumors and lymphomas has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition [Phase 1]
A Phase 1 bioequivalence study comparing 10 mg and 20 mg Senaparib capsules in healthy fasting Chinese subjects has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma [Phase 1]
Phase 1 trial evaluating metronomic chemotherapy in patients with advanced solid tumors with bone metastases and pretreated osteosarcoma. Re…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers [Phase 2]
A Phase 2 neoadjuvant trial evaluating pembrolizumab before surgery in mismatch repair–deficient locally advanced solid cancers has complete…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Study of SGN1 in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating SGN1 in patients with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy [Phase 1, Phase 2]
Genmab's GEN1053 antibody study in malignant solid tumors (Phase 1/2) was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation [Phase 1]
Phase 1 clinical trial update of HMBD-001, an anti-HER3 antibody, evaluating its use with or without chemotherapy in solid tumors with NRG1 …
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma [Phase 1]
Phase 1 study of PCLX-001 in relapsed/refractory advanced solid tumors and B-cell non-Hodgkin lymphoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H) [Phase 2]
Phase 2 MATCH subprotocol study evaluating copanlisib as a targeted treatment for cancers with PTEN expression. The trial is currently activ…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial update evaluating the combination of veliparib and irinotecan hydrochloride in patients with metastatic or unresectable solid …
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial update of a JAB-3312–based combination therapy in adults with advanced solid tumors has completed (status: completed), inclu…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U) [Phase 2]
Phase 2 MATCH subprotocol U update on defactinib (VS-6063) for cancers with NF2 genetic changes, with results posted and the trial listed as…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers [Phase 1]
Aplitabart (IGM-8444) Phase 1a/1b study in solid tumors and various hematologic cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V) [Phase 2]
Phase 2 NCI MATCH subprotocol V is evaluating sunitinib for cancers with cKIT genetic alterations, including advanced and refractory lymphom…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: GVAX Plus Checkpoint Blockade in Neuroblastoma [Phase 1]
The Phase 1 trial of GVAX plus checkpoint blockade in neuroblastoma was terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 [Phase 1, Phase 2]
Phase 1/2 trial of BNT411 in solid tumors and extensive-stage small cell lung cancer reported safety, pharmacokinetics, pharmacodynamics, an…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Text-based Intervention to Minimize the Time Burden of Routine Cancer Care [NA]
A completed clinical trial from the Abramson Cancer Center evaluated a text-based intervention to reduce the time burden of routine cancer c…